NYSEIndustrialsStaffing & Employment ServicesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for BGSF yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Invest in growth initiatives including PropTech throughout 2026 | BGSF is investing in growth initiatives like PropTech in 2026. | Intact | Growth initiatives investment stalls or is cut in 2026 | Qualitative condition This condition has no defined numerical measure. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a challenged, smaller-cap business with a possible growth-and-improvement story, not a proven durable compounder. The thesis is cautious and in a watch state, with low confidence because recent financial performance is weak relative to its industry cohort.
BGSF is described as cheap versus peers, but the valuation model has low confidence and shows a negative expectations gap. Fragility is rated low, so the evidence does not point to a broadly fragile setup; however, the business is loss-making and execution remains a concern.
Near term, management’s 2026 growth initiatives have early support: revenue rose from $20.9 million in the first quarter to $22.3 million in the second, and management still expects low- to mid-single-digit full-year growth versus 2025. Cost control has helped narrow the operating loss, but execution is mixed, and the recent results remain weak overall.
The multi-year thesis hinges on revenue growth continuing and PropTech gaining traction, while cost control translates into more reliable profitability. Near term, a guidance cut would be a meaningful negative; continued earnings strength and higher guidance from sector bellwethers PAYX, RHI, and KFY would support the sector backdrop, while misses or lower guidance could remove that support.
Over the next 1 to 3 years, BGSF’s case rests on whether growth initiatives and operating improvements can overcome weak recent performance and sector headwinds. The evidence supports a cautious view, with low confidence and results that need close monitoring. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| These steps could help BGSF return to profitability. |
| Improving |
| EPS remains negative beyond FY27 |
Diluted EPS: $-0.08 per share FY2026-Q2; GAAP. Published target: EPS >= $0 in FY27. Annual target cannot be compared with a quarterly or TTM observation. Aug 5, 2026-0.08 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Achieve low- to mid-single-digit revenue growth in 2026 | Management aims for low- to mid-single-digit revenue growth this year. | Intact | YoY revenue growth falls below 0% in FY26 | Revenue growth: -6.57% FY2026-Q3; GAAP. Published target: >=3% YoY revenue growth in FY26. Annual target cannot be compared with a quarterly or TTM observation. Nov 4, 2026-6.566276 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 3 supplied quarters. Management reported: “We continue to expect full-year 2026 revenue to grow in the low- to mid-single-digit range compared to 2025.” “Co-Chief Executive Officer and Chief Financial Officer, Keith Schroeder, said , “While revenue remained pressured by cautious customer spending, our focus on expense management and operational efficiency enabled us to sustain profitability and maintain a strong balance sheet.” Revenue was $25.129 million in 2026-Q3. Delivery assessment Nov 4, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.